Document Detail


Successful intrauterine therapy for fetal goitrous hypothyroidism during late gestation.
MedLine Citation:
PMID:  17917306     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We experienced a case of fetal goitrous hypothyroidism in an infant delivered by a 33-year-old woman receiving 300 mg/day of propylthiouracil (PTU) for hyperthyroidism due to Graves' disease. A large fetal goiter (maximum diameter, 60 mm) was detected by magnetic resonance imaging (MRI) at 36 weeks of gestation. Initial fetal blood sampling revealed hypothyroidism with a serum thyroid-stimulating hormone (TSH) of 99 microIU/mL, free triiodothyronine (T(3)) of 1.97 pg/mL, and free thyroxine (T(4)) of 0.29 ng/dL. Consequently, a diagnosis of fetal goitrous hypothyroidism due to transplacental passage of maternal PTU was made. To reduce the risk of perinatal complications, 300 microg of levothyroxine sodium (L-T(4)) was administered into the maternal amniotic fluid twice between 37 and 38 weeks of gestation. Subsequent fetal MRI showed that the size of goiter had decreased. At 38 weeks and 5 days of gestation, a 3042-g male infant was born by cesarean section. There were no severe complications at delivery, although mild tachypnea was observed and the infant's thyroid gland was slightly enlarged. He was treated with L-T(4) for two weeks. At present, his growth and neurological development are normal. This case indicates that intrauterine therapy by the intraamniotic administration of L-T(4) can be effective in treating fetal goitrous hypothyroidism even during late gestation.
Authors:
Ichiro Miyata; Noriko Abe-Gotyo; Asako Tajima; Hideki Yoshikawa; Satoshi Teramoto; Masami Seo; Kei-Ichi Kanno; Kentaro Sugiura; Tadao Tanaka; Yoshikatsu Eto
Related Documents :
1741876 - Developmental follow-up of very low birthweight premature infants with low free thyroxine.
9860166 - 1,2- and 1,4-cyclohexanediol: major urinary metabolites and biomarkers of exposure to c...
12727946 - Sex-specific impact of congenital hypothyroidism due to thyroid dysgenesis on skeletal ...
15129226 - Evidence for developmental hypopituitarism in ill preterm infants.
16203216 - Development of chemoreceptor responses in infants.
15815206 - A randomized formula controlled trial of bifidobacterium lactis and streptococcus therm...
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2007-10-03
Journal Detail:
Title:  Endocrine journal     Volume:  54     ISSN:  1348-4540     ISO Abbreviation:  Endocr. J.     Publication Date:  2007 Dec 
Date Detail:
Created Date:  2007-12-20     Completed Date:  2008-03-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9313485     Medline TA:  Endocr J     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  813-7     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, Jikei University School of Medicine, Tokyo, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Amniotic Fluid / drug effects
Antithyroid Agents / adverse effects,  therapeutic use
Congenital Hypothyroidism / chemically induced,  complications,  drug therapy*
Female
Fetal Diseases / drug therapy*
Fetal Therapies*
Gestational Age
Goiter / chemically induced,  complications,  drug therapy*
Graves Disease / complications,  drug therapy
Humans
Hyperthyroidism / drug therapy,  etiology
Infant, Newborn
Male
Maternal-Fetal Exchange / drug effects
Pregnancy
Pregnancy Trimester, Third
Propylthiouracil / adverse effects,  therapeutic use
Thyroxine / administration & dosage*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Antithyroid Agents; 51-52-5/Propylthiouracil; 7488-70-2/Thyroxine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A novel function of plant histone H1: microtubule nucleation and continuous plus end association.
Next Document:  Clinical significance of 1-year treatment with raloxifene on bone and lipid metabolism in Japanese p...